Business
Novavax to Participate in 2024 Jefferies Global Healthcare Conference
GAITHERSBURG, Md., May 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant,
About this update from Novavax, Inc.
[{"type":"text","content":"GAITHERSBURG, Md., May 30, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the 2024 Jefferies Global Healthcare Conference.\nConference Details:\nFireside Chat\nDate:\nThursday, June 6, 2024\nTime:\n12:30 – 12:55 p.m. Eastern Time (ET)\nLocation:\nNew York, NY\nModerator:\nRoger Song, MD, CFA, Equity Research Analyst – Biotechnology\nNovavax participant:\nJohn C. Jacobs, President and Chief Executive Officer \nConference\nEvent:\nInvestor Meetings\nDate:\nThursday, June 6, 2024\nRecordingsA replay of the recorded fireside session will be available through the Events & Presentations page of the Company's website at ir.novavax.com for 30 days from the date of the conference.\nAbout NovavaxNovavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. The Company's portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination and stand-alone influenza vaccine candidates. In addition, Novavax's adjuvant is included in the University of Oxford and Serum Institute of India's R21/Matrix-M malaria vaccine. Please visit novavax.com and LinkedIn for more information.\nContacts:InvestorsErika [email protected]\nMediaGiovanna [email protected]\n\n \n\n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-2024-jefferies-global-healthcare-conference-302158433.html\nSOURCE Novavax, Inc.","length":13066,"tagName":"div"}]